You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

X396

Showing 1 - 25 of 738
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Non Small Cell Lung Cancer Trial (Ensartinib Hydrochloride)

Not yet recruiting
  • Non Small Cell Lung Cancer
  • Ensartinib Hydrochloride
  • (no location specified)
Dec 15, 2022

NSCLC, ALK Gene Rearrangement Positive Trial in United States (Ensartinib)

Available
  • Non-Small Cell Lung Cancer
  • ALK Gene Rearrangement Positive
  • Stanford, California
  • +3 more
Oct 18, 2022

Advanced Solid Tumors, NSCLC Trial in United States (Phase I: X-396 (ensartinib), Phase II: X-396 (ensartinib))

Completed
  • Advanced Solid Tumors
  • Non-small Cell Lung Cancer
  • Phase I: X-396 (ensartinib)
  • Phase II: X-396 (ensartinib)
  • Duarte, California
  • +13 more
Oct 4, 2021

NSCLC Trial in Tianjin (Ensartinib, Placebo)

Recruiting
  • Non-small Cell Lung Cancer
  • Tianjin, China
    TianJin Medical University Cancer Institute & Hospital
Jul 13, 2022

NSCLC Trial in Guangzhou (Avitinib Maleate, Afatinib, Crizotinib)

Recruiting
  • Carcinoma, Non-Small-Cell Lung
  • Avitinib Maleate
  • +13 more
  • Guangzhou, Guangdong, China
    Guangdong Lung Cancer Institute, Guangdong Provincial People's H
Dec 3, 2022

NSCLC Trial in Shijiazhuang (Ensartinib)

Not yet recruiting
  • Non-small Cell Lung Cancer
  • Shijiazhuang, Hebei, China
    Jun Feng Liu
Feb 6, 2022

Solid Tumor, NSCLC Metastatic Trial in Guanzhou (Ensartinib)

Recruiting
  • Solid Tumor
  • Non-Small Cell Lung Cancer Metastatic
  • Guanzhou, Guangdong, China
    Sun yat-sen Univerisity Cancer Center
Nov 22, 2021

ALK Fusion Protein Expression, Adjuvant Therapy, NSCLC Trial (Ensatinib, chemo)

Not yet recruiting
  • ALK Fusion Protein Expression
  • +2 more
  • (no location specified)
Jan 10, 2022

Metastatic Lung Non-Small Cell Carcinoma, Recurrent Lung Non-Small Cell Carcinoma, Stage IIIC Lung Cancer AJCC v8 Trial in

Recruiting
  • Metastatic Lung Non-Small Cell Carcinoma
  • +5 more
  • Bevacizumab
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Jul 13, 2022

NSCLC Trial in Worldwide (X-396 (ensartinib), crizotinib)

Active, not recruiting
  • Non-small Cell Lung Cancer
  • Phoenix, Arizona
  • +122 more
Oct 21, 2022

Lung Cancer, ROS1 Gene Rearrangement Trial in Shanghai (X-396 Capsule)

Unknown status
  • Lung Cancer
  • ROS1 Gene Rearrangement
  • X-396 Capsule
  • Shanghai, Shanghai, China
    Chest hospital affiliated to Shanghai jiao tong university
Jan 6, 2020

Lung Cancer Trial in Shanghai (ensartinib capsules (test product), ensartinib capsules (reference product))

Completed
  • Lung Cancer
  • ensartinib capsules (test product)
  • ensartinib capsules (reference product)
  • Shanghai, Shanghai, China
    Shanghai Public Health Clinical Center
Jul 22, 2019

Nonsmall Cell Lung Cancer, Brain Metastases Trial (X-396(Ensartinib) Capsule)

Unknown status
  • Nonsmall Cell Lung Cancer
  • Brain Metastases
  • X-396(Ensartinib) Capsule
  • (no location specified)
Nov 22, 2018

ALK-POSITIVE NSCLC Trial in Nanjing (Ensartinib)

Unknown status
  • ALK-POSITIVE NSCLC
  • Nanjing, Jiangsu Provence, China
    Jiangsu Province Hospital Affiliated to Nanjing Madical Universi
Jan 14, 2019

Advanced Malignant Solid Tumor, Ann Arbor Stage III Non-Hodgkin Lymphoma, Ann Arbor Stage IV Non-Hodgkin Lymphoma Trial in

Recruiting
  • Advanced Malignant Solid Neoplasm
  • +44 more
  • Biopsy
  • +23 more
  • Birmingham, Alabama
  • +166 more
Feb 2, 2023

NSCLC, Carcinoma, NSCLC Trial in New York (Ensartinib, Durvalumab)

Completed
Has Results
  • Non-small Cell Lung Cancer
  • +2 more
  • New York, New York
    Research Facility
Oct 25, 2018

Malignant Solid Tumor, Recurrent Ependymoma, Recurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor Trial in Puerto

Recruiting
  • Malignant Solid Neoplasm
  • +26 more
  • Birmingham, Alabama
  • +121 more
Aug 24, 2022

After Transcatheter Closure Of VSD In Children

Recruiting
  • VSD Children
  • ECG
  • Sohag, Egypt
    Sohag University hospitals
Jun 5, 2023

Chronic Liver Disease Trial in Hong Kong (BNT162b2, CoronaVac, AZD1222)

Recruiting
  • Chronic Liver Disease
  • BNT162b2
  • +2 more
  • Hong Kong, Hong Kong
    Humanity & Health Medical Group Limited
Aug 1, 2022

Patients With Pulmonary Hypertension

Not yet recruiting
  • Pulmonary Hypertension
    • San Francisco, California
      Power Life Sciences
    Jun 23, 2023

    Pleural Effusion Trial in Taoyuan City (Chang Gung Pleural Effusion Detection Software)

    Not yet recruiting
    • Pleural Effusion
    • Chang Gung Pleural Effusion Detection Software
    • Taoyuan City, Taiwan
      Chang Gung memorial hospital
    Jun 6, 2023

    Multiple Sclerosis Trial in New York (High Intensity Interval Gait training, Moderate Intensity Interval gait training)

    Recruiting
    • Multiple Sclerosis
    • High Intensity Interval Gait training
    • Moderate Intensity Interval gait training
    • New York, New York
      Hunter College
    Oct 5, 2022

    Pneumothorax Trial in Taoyuan City (Chang Gung Pneumothorax Detection Software)

    Not yet recruiting
    • Pneumothorax
    • Chang Gung Pneumothorax Detection Software
    • Taoyuan City, Taiwan
      Chang Gung memorial hospital
    Jun 6, 2023

    NSCLC, Stage III Trial in Germany (Durvalumab Injection [Imfinzi], Thoracic Radiotherapy (TRT) conventionally, Thoracic

    Recruiting
    • NSCLC, Stage III
    • Durvalumab Injection [Imfinzi]
    • +2 more
    • Aachen, Germany
    • +13 more
    Nov 29, 2022

    Effects of Abrocitinib Treatment on Skin Barrier Function

    Recruiting
    • Atopic Dermatitis
    • No Intervention
    • Kiel, Schleswig-Holstein, Germany
      UKSH, Campus Kiel
    Dec 28, 2022